跳至主要内容
临床试验/NCT03127202
NCT03127202已完成不适用

Evaluation of Left Ventricular Pacing Vectors Use in Phrenic Nerve Stimulation Management and Left Ventricular Parameters Adjustment

LivaNova19 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2012年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
LivaNova
入组人数
90
试验地点
19
主要终点
Phrenic nerve stimulation measurement

研究概览

简要总结

Evaluation of three left ventricular pacing polarities effectiveness to narrow phrenic nerve stimulation.

详细描述

The primary endpoint of the study aims at demonstrating that the three left ventricular polarities in the Cardiac Resynchronisation Therapy-Defibrillator could bypass phrenic nerve stimulation at least in 90% of implants.

Success was defined as an absence of phrenic nerve stimulation (threshold > 7V) or in case of phrenic nerve stimulation occurrence (threshold < 7V), as the resolution of the phrenic nerve stimulation by reprogramming one of the 3 left ventricular pacing polarities available in the device : left ventricular tip- left ventricular ring (bipolar), left ventricular tip- right ventricular ring (pseudo-bipolar) and left ventricular ring-right ventricular coil.

Any occurrence of phrenic nerve stimulation without resolution by reprogramming was considered as a failure.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible for an implantation of a Cardiac Resynchronization Therapy-Defibrillator according to relevant regulations (will be only tolerated primo-implantation and upgrade)
  • Patient scheduled for implantation of a Cardiac Resynchronization Therapy-Defibrillator
  • Patient has given his informed consent

排除标准

  • Any contraindication for Implantable Cardioverter Defibrillator therapy
  • Heart transplantation or waiting for heart transplantation
  • Implanted with a ventricular assist device (VAD)
  • Inability to understand the purpose of the study or to cooperate
  • Not available for routine follow-up visits
  • Life expectancy less than 12 months
  • Age of less than 18 years and et pregnancy
  • Under guardianship

结局指标

主要结局

Phrenic nerve stimulation measurement

时间窗: The presence of phrenic nerve stimulation will be assessed at implant.

The presence of phrenic nerve stimulation at 10 Volt, using a pacing system analyzer

次要结局

未报告次要终点

研究者

发起方
LivaNova
申办方类型
Industry
责任方
Sponsor

研究点 (19)

Loading locations...

相似试验